Sunday , December 16 2018
Latest Article
Home / Blog / Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

http://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bddf4b2ba-e758-465e-92d4-c0feeadaf10f%7D/shire-acquires-foresight-biotherapeutics-for-300-million?dul%3b=&ecp=&utm_source=maestro&utm_medium=email&utm_campaign=ophthalmology+news

 

Bausch + Lomb receives 510(k) clearance for modified Victus interface kit

http://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bc3e915ae-8d3d-44be-ab71-d3755d20f745%7D/bausch–lomb-receives-510k-clearance-for-modified-victus-interface-kit?dul%3b=&ecp=&utm_source=maestro&utm_medium=email&utm_campaign=ophthalmology+news

 

Omeros receives marketing authorization for Omidria in European Union

http://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B2eebab5f-4dd2-497a-86bf-5a76d9815920%7D/omeros-receives-marketing-authorization-for-omidria-in-european-union?dul%3b=&ecp=&utm_source=maestro&utm_medium=email&utm_campaign=ophthalmology+news

About Gloria Wu

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>